Petra Windthorst1, Nazar Mazurak2, Marvin Kuske3, Arno Hipp4, Katrin E Giel5, Paul Enck6, Andreas Nieß7, Stephan Zipfel8, Martin Teufel9. 1. Department of Psychosomatic Medicine and Psychotherapy, University Hospital, University of Tuebingen, Germany. Electronic address: petra.windthorst@med.uni-tuebingen.de. 2. Department of Psychosomatic Medicine and Psychotherapy, University Hospital, University of Tuebingen, Germany. Electronic address: nazar.mazurak@gmail.com. 3. Department of Psychosomatic Medicine and Psychotherapy, University Hospital, University of Tuebingen, Germany. Electronic address: marvin.kuske@gmx.de. 4. Department of Sports Medicine, University Hospital, University of Tuebingen, Germany. Electronic address: arno.hipp@uni-tuebingen.de. 5. Department of Psychosomatic Medicine and Psychotherapy, University Hospital, University of Tuebingen, Germany. Electronic address: katrin.giel@med.uni-tuebingen.de. 6. Department of Psychosomatic Medicine and Psychotherapy, University Hospital, University of Tuebingen, Germany. Electronic address: paul.enck@uni-tuebingen.de. 7. Department of Sports Medicine, University Hospital, University of Tuebingen, Germany. Electronic address: andreas.niess@med.uni-tuebingen.de. 8. Department of Psychosomatic Medicine and Psychotherapy, University Hospital, University of Tuebingen, Germany. Electronic address: stephan.zipfel@med.uni-tuebingen.de. 9. Department of Psychosomatic Medicine and Psychotherapy, University Hospital, University of Tuebingen, Germany. Electronic address: martin.teufel@med.uni-tuebingen.de.
Abstract
OBJECTIVE:Chronic fatigue syndrome (CFS) is characterised by persistent fatigue, exhaustion, and several physical complaints. Research has shown cognitive behavioural therapy (CBT) and graded exercise training (GET) to be the most effective treatments. In a first step we aimed to assess the efficacy of heart rate variability biofeedback therapy (HRV-BF) as a treatment method comprising cognitive and behavioural strategies and GET in the pilot trial. In a second step we aimed to compare both interventions with regard to specific parameters. METHODS: The study was conducted in an outpatient treatment setting. A total of 28 women with CFS (50.3±9.3years) were randomly assigned to receive either eight sessions of HRV-BF or GET. The primary outcome was fatigue severity. Secondary outcomes were mental and physical quality of life and depression. Data were collected before and after the intervention as well as at a 5-month follow-up. RESULTS:General fatigue improved significantly after both HRV-BF and GET. Specific cognitive components of fatigue, mental quality of life, and depression improved significantly after HRV-BF only. Physical quality of life improved significantly after GET. There were significant differences between groups regarding mental quality of life and depression favouring HRV-BF. CONCLUSION: Both interventions reduce fatigue. HRV-BF seems to have additional effects on components of mental health, including depression, whereas GET seems to emphasise components of physical health. These data offer implications for further research on combining HRV-BF and GET in patients with CFS. TRIAL REGISTRATION: The described trial has been registered at the International Clinical Trials Registry Platform following the number DRKS00005445.
RCT Entities:
OBJECTIVE:Chronic fatigue syndrome (CFS) is characterised by persistent fatigue, exhaustion, and several physical complaints. Research has shown cognitive behavioural therapy (CBT) and graded exercise training (GET) to be the most effective treatments. In a first step we aimed to assess the efficacy of heart rate variability biofeedback therapy (HRV-BF) as a treatment method comprising cognitive and behavioural strategies and GET in the pilot trial. In a second step we aimed to compare both interventions with regard to specific parameters. METHODS: The study was conducted in an outpatient treatment setting. A total of 28 women with CFS (50.3±9.3years) were randomly assigned to receive either eight sessions of HRV-BF or GET. The primary outcome was fatigue severity. Secondary outcomes were mental and physical quality of life and depression. Data were collected before and after the intervention as well as at a 5-month follow-up. RESULTS: General fatigue improved significantly after both HRV-BF and GET. Specific cognitive components of fatigue, mental quality of life, and depression improved significantly after HRV-BF only. Physical quality of life improved significantly after GET. There were significant differences between groups regarding mental quality of life and depression favouring HRV-BF. CONCLUSION: Both interventions reduce fatigue. HRV-BF seems to have additional effects on components of mental health, including depression, whereas GET seems to emphasise components of physical health. These data offer implications for further research on combining HRV-BF and GET in patients with CFS. TRIAL REGISTRATION: The described trial has been registered at the International Clinical Trials Registry Platform following the number DRKS00005445.
Authors: Jennifer F Buckman; Bronya Vaschillo; Evgeny G Vaschillo; Elizabeth E Epstein; Tam T Nguyen-Louie; Laura M Lesnewich; David Eddie; Marsha E Bates Journal: Psychol Addict Behav Date: 2019-11-18
Authors: Ana Isabel Penzlin; Kristian Barlinn; Ben Min-Woo Illigens; Kerstin Weidner; Martin Siepmann; Timo Siepmann Journal: BMC Psychiatry Date: 2017-09-06 Impact factor: 3.630
Authors: Daniel Jaramillo-Quintanar; Irving A Cruz-Albarran; Veronica M Guzman-Sandoval; Luis A Morales-Hernandez Journal: Sensors (Basel) Date: 2020-07-28 Impact factor: 3.576
Authors: Claire L Macnamara; Erin Cvejic; Gordon B Parker; Andrew R Lloyd; Gina Lee; Jessica E Beilharz; Ute Vollmer-Conna Journal: Trials Date: 2018-07-11 Impact factor: 2.279